Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain ACCESS Newswire - Tue Apr 22, 11:01AM CDT

BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

SNOA : 3.49 (-2.24%)
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) ACCESS Newswire - Mon Mar 10, 11:01AM CDT

BOULDER, CO / ACCESS Newswire / March 10, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

SNOA : 3.49 (-2.24%)
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando ACCESS Newswire - Tue Feb 25, 10:01AM CST

BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

SNOA : 3.49 (-2.24%)
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results ACCESS Newswire - Wed Feb 5, 10:05AM CST

Revenues increased 14% for the quarter compared to prior year and 13% year-to-date

SNOA : 3.49 (-2.24%)
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices ACCESS Newswire - Thu Dec 5, 2024

BOULDER, CO / ACCESSWIRE / December 5, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

SNOA : 3.49 (-2.24%)
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States ACCESS Newswire - Thu Nov 21, 2024

BOULDER, CO / ACCESSWIRE / November 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

SNOA : 3.49 (-2.24%)
Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States ACCESS Newswire - Wed Aug 21, 2024

BOULDER, CO / ACCESSWIRE / August 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

SNOA : 3.49 (-2.24%)
Investors Chat: Instacart IPO Motley Fool - Sun Sep 3, 2023

Instacart is profitable and growing. Is that enough to spark investor interest?

NFLX : 100.24 (-2.89%)
CPB : 29.60 (+0.82%)
LYV : 139.33 (-0.25%)
PEP : 145.02 (-1.29%)
SNOA : 3.49 (-2.24%)
UBER : 91.32 (+0.36%)
DASH : 225.00 (+1.72%)
AMZN : 229.53 (+0.18%)
WMT : 115.11 (+0.24%)
MCD : 311.23 (+0.87%)
DIS : 105.30 (-0.16%)
Augmented Reality Devices: Apple vs. Meta Platforms Motley Fool - Sat Jun 17, 2023

Plus, how to plan for a healthier retirement.

TMUS : 209.63 (+0.78%)
META : 673.42 (+1.80%)
AAPL : 278.78 (-0.68%)
VZ : 41.69 (+1.04%)
T : 25.28 (-0.43%)
SNOA : 3.49 (-2.24%)
UBER : 91.32 (+0.36%)
COIN : 269.73 (-1.58%)
Sonoma Pharmaceuticals (NASDAQ: SNOA) and EMC Pharma Receives DAPA Registration for Microcyn Rx Products from U.S. Department of Defense Spotlight Growth - Wed Jan 25, 2023

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is a global healthcare company that is focused on the research, development and production of

SNOA : 3.49 (-2.24%)

Barchart Exclusives

Rate Decision, Tech Earnings and Other Key Things to Watch this Week Barchart - 1 hour ago
Markets face the year's final major policy week as the Federal Reserve's December meeting Wednesday afternoon will determine whether the central bank delivers another rate cut or pauses its easing cycle amid mixed economic signals and persistent inflation concerns. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot